Benefits of ExoQuick ULTRA
- Even cleaner — reduces carry-over of albumins by 75% and immunoglobulins by 40% more than other methods, including ultracentrifugation and competitors’ kits
- Higher yields — isolate more EVs per normalized input volume than ultracentrifugation and competitors’ kits
- Better biomarker detection — see what you’ve been missing when you increase the sensitivity of EV biomarker detection by up to 11-fold (CD9) and 8-fold (CD81)
- Fast — requires less than 20-minutes of hands-on time, including a convenient column-based format for clean-up
- Cost-effective — save money with each reaction compared to how much you’ll spend using a competitor’s kit
Looking to isolate EVs from Tissue Culture Media or other biofluids? Check out ExoQuick-TC ULTRA.
Uncompromising EV isolation delivers higher yields and cleaner preps
Drawing upon our years of exosome experience, the SBI team has pushed ExoQuick extracellular vesicle (EV) isolation technology to new peaks of performance with ExoQuick ULTRA for Serum & Plasma. While many EV isolation methods require you to choose between high yields, easy protocols, clean preps, and low costs, ExoQuick ULTRA is able to deliver on all these fronts for trade-off free EV preparation.
Important for intercellular communication in both normal physiology as well as disease states such as cancer, EV biology is rapidly growing field. However, obtaining EVs for in vivo and ex vivo studies can be challenging. Ultracentrifugation has been considered the gold standard for exosome isolation, but the method is time-consuming, requires large sample volume inputs and requires access to specialized equipment. Additionally, UC doesn’t isolate the cleanest exosome preparations it once was thought to produce. Other commercial kit methods are faster and easier than ultracentrifugation, but still include carryover protein that can cause over-estimation of EV amount and that can interfere with protein-sensitive studies such as mass spectrometry.
Fortunately, the SBI team is never content with good enough and has continued to improve our ExoQuick technology. Now, with our newest generation of ExoQuick—ExoQuick ULTRA—you no longer have to make the trade-off between yield, purity, speed, a simple protocol, and price. From as little as 250 μL of serum or plasma and our ExoQuick ULTRA kit, you can isolate high-quality EVs for a wide range of downstream applications such as such as western blotting, mass spectrometry, NGS sequencing, exosome labeling, and in vivo/ex vivo exosome delivery.
Each ExoQuick ULTRA Kit for Serum and Plasma comes with enough ExoQuick ULTRA (serum/plasma) reagent and convenient, pre-packed columns to complete 20 reactions*.
*1 reaction is defined as 250 μL of serum or plasma precipitated using ExoQuick ULTRA
List of components
|Purification column||20 columns||4°C|
|Collection tubes||20 tubes||RT|
|2 ml Eppendorf tubes||20 tubes||RT|
|Buffer A||5 ml||4°C|
|Buffer B||30 ml||4°C|
The kit is shipped on blue ice and the components should be stored at recommended temperatures as stated above.
Properly stored kits are stable for 12 months from the date received.
Get high levels of miRs from our Human pre-miRNA Expression Lentivectors
Figure 1. ExoQuick ULTRA delivers high yields of clean exosomes. (A) A coomassie blue-stained protein gel comparing the protein content of exosome preps isolated using different methods shows only a few, defined protein bands in the ExoQuick ULTRA lane compared to the other methods. (B) Western blotting of the gel shows that the ExoQuick ULTRA prep contains the highest levels of exosome-specific markers CD9, CD81, and Hsp70 and the lowest levels of the carryover proteins albumin and IgGH. In contrast, the prep from Company Q appears to be primarily albumin, and even the sample prepared using ultracentrifugation contains considerably higher levels of both albumin and IgGH. Each lane was loaded with 7 μg of total protein as measured using a fluorometric Qubit protein assay.
- Winston, C, et al. (2019) Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer’s disease dementia. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2019 Dec 1; 11:61-66. Link: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Kim, Y & Mok, H. (2019) Citraconylated exosomes for improved internalization into macrophages. Appl Biol Chem. 2019 Dec 1; 62(1). Link: Appl Biol Chem
- Saunders, CA, et al. (2019) Genetic manipulation of PLB-985 cells and quantification of chemotaxis using the underagarose assay. Methods Cell Biol.. 2019 Oct 29; 149:31-56. PM ID: 30616826
- Sekiba, K, et al. (2019) Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction. Cell Mol Gastroenterol Hepatol. 2019 Oct 24; 7(2):297-312. PM ID: 30704981
- Yang, JS, et al. (2019) Investigation of lipidomic perturbations in oxidatively stressed subcellular organelles and exosomes by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry. Anal. Chim. Acta. 2019 Sep 27; 1073:79-89. PM ID: 31146839
- Ishihara, R, et al. (2019) Design of a surface-functionalized power-free microchip for extracellular vesicle detection utilizing UV grafting. Reactive and Functional Polymers. 2019 Sep 1; 142:183-188. Link: Reactive and Functional Polymers
- Gamboa, L, et al. (2019) Heat-triggered remote control of CRISPR-dCas9 for tunable transcriptional modulation. bioRxiv. 2019 Aug 14;. Link: bioRxiv
- Liu, L, et al. (2019) IL‑17A promotes CXCR2‑dependent angiogenesis in a mouse model of liver cancer. Mol Med Rep. 2019 Aug 1; 20(2):1065-1074. PM ID: 31173199
- Xu, Q, et al. (2019) miR‑132 inhibits high glucose‑induced vascular smooth muscle cell proliferation and migration by targeting E2F5. Mol Med Rep. 2019 Aug 1; 20(2):2012-2020. PM ID: 31257477
- Hisano, Y, et al. (2019) Lysolipid receptor cross-talk regulates lymphatic endothelial junctions in lymph nodes. J. Exp. Med.. 2019 Jul 1; 216(7):1582-1598. PM ID: 31147448
- Choi, YW, et al. (2019) Abrogation of B-RafV600E induced senescence by FoxM1 expression. Biochem. Biophys. Res. Commun.. 2019 Jun 30;. PM ID: 31270027
- Madhu, LN, et al. (2019) Neuroinflammation in Gulf War Illness is linked with HMGB1 and complement activation, which can be discerned from brain-derived extracellular vesicles in the blood. Brain Behav. Immun.. 2019 Jun 27;. PM ID: 31255677
- Amado, F, et al. (2019) Sample Treatment for Saliva Proteomics. Adv. Exp. Med. Biol.. 2019 Jun 26; 1073:23-56. PM ID: 31236838
- Tian, L, et al. (2019) Long-read sequencing unveils IGH-DUX4 translocation into the silenced IGH allele in B-cell acute lymphoblastic leukemia. Nat Commun. 2019 Jun 26; 10(1):2789. PM ID: 31243274
- Chen, CY, et al. (2019) Extracellular vesicles from human urine-derived stem cells prevent osteoporosis by transferring CTHRC1 and OPG. Bone Res. 2019 Jun 26; 7:18. PM ID: 31263627
- Zhang, L & Li, D. (2019) MORC2 regulates DNA damage response through a PARP1-dependent pathway. Nucleic Acids Research. 2019 Jun 25;. Link: Nucleic Acids Research
- Ariyoshi, K, et al. (2019) Radiation-Induced Bystander Effect is Mediated by Mitochondrial DNA in Exosome-Like Vesicles. Sci Rep. 2019 Jun 24; 9(1):9103. PM ID: 31235776
- Lee, H, et al. (2019) Caveolin-1 selectively regulates microRNA sorting into microvesicles after noxious stimuli. J. Exp. Med.. 2019 Jun 24;. PM ID: 31235510
- Zhao, J, et al. (2019) Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer. Cancers (Basel). 2019 Jun 22; 11(6). PM ID: 31234517
- Wang, X, et al. (2019) Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma. Biomed. Pharmacother.. 2019 Jun 20; 117:109109. PM ID: 31229922